Short answer
MERIT MEDICAL SYSTEMS INC (MMSI) filed an 8-K current report with the SEC on April 30, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Merit’s earnings disclosure includes non-GAAP results and reconciliations in Exhibits 99.1 and 99.2.
MERIT MEDICAL SYSTEMS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Merit’s earnings disclosure includes non-GAAP results and reconciliations in Exhibits 99.1 and 99.2
- Management provides GAAP revenue guidance but excludes other GAAP measures
- Unpredictable acquisition, amortization, litigation, regulatory, and compensation costs may materially affect GAAP results
- Investors should rely on exhibit-level results and reconciliations when assessing underlying performance
Item 7.01 · Regulation FD Disclosure
- Conference call covers operating and financial results for quarter ended March 31, 2026
- Live webcast and slide presentation available on Merit’s website
- Exhibit 99.2 contains investor presentation materials for the results discussion
Item EX-99.1 · Exhibit EX-99.1
- Q1 revenue $381.9M, up 7%; organic constant-currency growth 3.7% excluding DualCap divestiture
- Non-GAAP operating margin improved to 19.7% from 19.3%; non-GAAP EPS rose 9% to $0.94
- GAAP EPS increased 39% to $0.68, aided by a $12.5M gain on business disposition
- View Point acquisition adds oncology products for $140M; $90M paid upfront and expected to dilute 2026 non-GAAP EPS by $0.05
- 2026 revenue guidance raised to $1.612B-$1.634B; EPS guidance unchanged at $4.01-$4.15
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MERIT MEDICAL SYSTEMS INC 8-K filings
Get the next MMSI 8-K as it lands
Follow MMSI for push alerts, or ask the research agent what this filing means.